These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10213076)

  • 1. Actions of butyrophenones and other antipsychotic agents at NMDA receptors: relationship with clinical effects and structural considerations.
    Shim SS; Grant ER; Singh S; Gallagher MJ; Lynch DR
    Neurochem Int; 1999 Feb; 34(2):167-75. PubMed ID: 10213076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors.
    Lynch DR; Gallagher MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):154-61. PubMed ID: 8858988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of the N-methyl-D-aspartate receptor channel to butyrophenones is dependent on the epsilon2 subunit.
    Yamakura T; Sakimura K; Mishina M; Shimoji K
    Neuropharmacology; 1998 Jun; 37(6):709-17. PubMed ID: 9707284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B-specific interactions.
    Gallagher MJ; Huang H; Lynch DR
    J Neurochem; 1998 May; 70(5):2120-8. PubMed ID: 9572299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats.
    Ossowska K; Pietraszek M; Wardas J; Nowak G; Wolfarth S
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):280-7. PubMed ID: 10344526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
    Sharma TA; Reynolds IJ
    J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain.
    McCoy L; Richfield EK
    Neurosci Lett; 1996 Aug; 213(2):137-41. PubMed ID: 8858627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular modulation of NMDA receptor function by antipsychotic drugs.
    Leveque JC; Macías W; Rajadhyaksha A; Carlson RR; Barczak A; Kang S; Li XM; Coyle JT; Huganir RL; Heckers S; Konradi C
    J Neurosci; 2000 Jun; 20(11):4011-20. PubMed ID: 10818136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
    Duncan GE; Moy SS; Lieberman JA; Koller BH
    Pharmacol Biochem Behav; 2006 Nov; 85(3):481-91. PubMed ID: 17097724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits.
    Schmitt A; Zink M; Müller B; May B; Herb A; Jatzko A; Braus DF; Henn FA
    Neurochem Res; 2003 Feb; 28(2):235-41. PubMed ID: 12608697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cells.
    Karasawa J; Yamamoto H; Yamamoto T; Sagi N; Horikomi K; Sora I
    Life Sci; 2002 Feb; 70(14):1631-42. PubMed ID: 11991251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J; Rajakumar N
    Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats.
    Toua C; Brand L; Möller M; Emsley RA; Harvey BH
    Neuroscience; 2010 Jan; 165(2):492-9. PubMed ID: 19854242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro.
    Arvanov VL; Liang X; Schwartz J; Grossman S; Wang RY
    J Pharmacol Exp Ther; 1997 Oct; 283(1):226-34. PubMed ID: 9336328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
    Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.
    Duncan GE; Moy SS; Lieberman JA; Koller BH
    Psychopharmacology (Berl); 2006 Jan; 184(2):190-200. PubMed ID: 16362405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.